We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.
- Authors
Stopeck, Alison T; Lipton, Allan; Body, Jean-Jacques; Steger, Guenther G; Tonkin, Katia; de Boer, Richard H; Lichinitser, Mikhail; Fujiwara, Yasuhiro; Yardley, Denise A; Viniegra, María; Fan, Michelle; Jiang, Qi; Dansey, Roger; Jun, Susie; Braun, Ada
- Abstract
This randomized study compared denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κ B (RANK) ligand, with zoledronic acid in delaying or preventing skeletal-related events (SREs) in patients with breast cancer with bone metastases.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Vol 28, Issue 35, p5132
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.29.7101